As cardiovascular disease is the most common cause of mortality in the developed world, it is natural that a great deal of emphasis should be placed on devices used to treat advanced cardiovascular disease, particularly arrhythmias and congestive heart failure.
This report, Cardiac Rhythm Device Markets, includes cardiac rhythm management devices with both external and internal applications. Major segments include defibrillators: electrical devices that deliver therapeutic levels of energy to the heart muscle for the treatment of ventricular defibrillation. pacemakers: small electrical generators that control a patient’s heartbeat.
These cardiac rhythm devices are broken into further segments with market sizing and forecasts to 2019:
• Sales of Cardiac Defibrillator by Type (External, Implantable)
• Sales of External Defibrillators by Product Type, (AEDs, Professional/Manual Defibrillators)
• Sales of Implantable Cardiac Defibrillators by Product Type, 2015 (Standard ICD, CRT-D)
• Sales of Cardiac Pacemaker by External and Implantable Types
• Sales of Implantable Cardiac Pacemakers by Product Type (Standard ICP, CRT-P)
as one cardiovascular condition very often influences the onset of others (e.g., hypertension resulting in stroke or congestive heart failure or atherosclerosis resulting in angina or myocardial infarction) there is urgency to discovering the root causes of cardiovascular disease in the hopes of not only treating the initial conditions, but also preventing them.
Cardiovascular disease is an international problem and the focus of major world healthcare systems. The report also provides overall rhythm management device market size and forecast (2014-2019) for each of the following countries:
• United States
Major participants are discussed in the report, including:
• Boston Scientific
• Cardiac Science Corporation
• Medtronic, Inc.
• Nihon Kohden
• Philips Healthcare
• Schiller AG
• Sorin Group
• St. Jude Medical
• ZOLL Medical Corporation
Primary sources include telephone interviews and email correspondence with more than 100 key industry officials, consultants, health care providers, and government personnel on the topic of cardiac rhythm management. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with company representatives included marketing directors, division managers, and product representatives.
Secondary sources such as company literature, databases, investment reports, and medical, information technology and business journals were used to complement primary information.
The base year for the report is 2015, with forecasts provided for each year through 2020. The market was evaluated via a combination of disease prevalence trends, population trends, device innovations, federal and industry standards and regulations. Both primary and secondary sources were consulted in developing market estimates.